Efficacy and safety of obefazimod in patients with moderately to severely active ulcerative colitis: results from two, phase 3, randomised, double-blind, placebo-controlled, 8-wee…

B Siegmund, B E Sands, S Danese, L Peyrin-Biroulet, M Dubinsky, T Hisamatsu, H Tilg, R Atreya, A Armuzzi, X Treton, F Baert, U Seidler, S Howaldt, F Cataldi, D Jacobstein, C J Rabbat, K Shan, G A Duvall, P S Dulai, D T Rubin, S Vermeire · Zeitschrift für Gastroenterologie · 2026 · Heft 08 · S. e319-e320